Europace Advance Access published online on October 6, 2009
Europace, doi:10.1093/europace/eup299
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL RESEARCH
Feasibility and outcome of epicardial pulmonary vein isolation for lone atrial fibrillation using minimal invasive surgery and high intensity focused ultrasound
1 Department of Cardiothoracic Surgery, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands; 2 Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 3 Department of Anaesthesia, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 4 The Interuniversity Cardiology Institute Netherlands, Utrecht, The Netherlands
Aims: Transvenous pulmonary vein isolation (PVI) is the cornerstone of non-pharmacological rhythm control therapy in symptomatic atrial fibrillation (AF). Success and complications rates are, however, still not optimal. New techniques and energy sources are therefore being developed.
Methods and results: Fifteen patients with lone AF refractory for antiarrhythmic drugs (AADs) underwent PVI by minimal invasive epicardial off-pump monolateral right-sided video-assisted thoracic surgery (VATS) using the UltraCinch with high-intensity focused ultrasound (HIFU). Primary endpoint was successful ablation defined as absence of AF or atrial flutter/tachycardia after 6 months assessed by complaints, 12 lead electrocardiogram, and 96 h Holter monitoring. Secondary endpoints were ablation success at the end of follow-up irrespective of AADs use or re-ablation and complications related to the procedure. Mean age was 47 ± 10 years and 14 (93%) were male. Eleven (73%) had paroxysmal, and 4 (27%) patients had persistent AF. Median AF history was 5 (1–12) years. At 6 months, six (40%) patients had sinus rhythm after one epicardial PVI (four on AADs). After 1.3 ± 0.6 years, four (27%) patients had sinus rhythm after one epicardial PVI (two on AADs) and in six (40%) patients endocardial radiofrequency re-ablation was performed, which was successful in three patients (20%). Two patients (13%) were planned for re-ablation. Three others (20%) refused re-ablation. Two major complications occurred (one late tamponade and one bleeding during surgery, necessitating sternotomy).
Conclusion: Epicardial PVI using monolateral right-sided VATS with the UltraCinch delivering HIFU is feasible, but is associated with substantial complications. Furthermore, the success rate was low. More research is therefore warranted to assess optimal ablation techniques and energy sources to perform PVI.
Trial Registration: clinicaltrials.gov Identifier: NCT00448656 [ClinicalTrials.gov] .
Key Words: Lone atrial fibrillation, Epicardial, Ablation, Minimal invasive surgery, HIFU
* Corresponding author. Tel: +31 50 3611327, Fax: +31 50 3614391, Email: i.c.van.gelder{at}thorax.umcg.nl
Manuscript submitted 16 July 2009. Accepted after revision 9 September 2009.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. J. Damiano Surgical ablation of lone atrial fibrillation on the beating heart: the chaos continues Europace, February 5, 2010; (2010) eup442v1. [Full Text] [PDF]
|
|